Á lódáil...
Clinically Observed Estrogen Receptor Alpha Mutations within the Ligand-Binding Domain Confer Distinguishable Phenotypes
OBJECTIVE: 20–50% of estrogen receptor-positive (ER+) metastatic breast cancers express mutations within the ER ligand-binding domain (LBD). While most studies focused on the constitutive ER signaling activity commonly engendered by these mutations selected during estrogen deprivation therapy, our s...
Na minha lista:
Foilsithe in: | Oncology |
---|---|
Main Authors: | , , , , , , , , , , , , , , , |
Formáid: | Artigo |
Teanga: | Inglês |
Foilsithe: |
2018
|
Ábhair: | |
Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5828968/ https://ncbi.nlm.nih.gov/pubmed/29306943 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000485510 |
Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|